Jane Yuet Ching Hui
- Oncology top 0.2%
- Pulmonary and Respiratory Medicine top 1%
- Cancer Research top 0.5%
- Immunology top 1%
- Molecular Biology top 10%
- Co-authors
- Hiroji IwataLuciana MolineroCarlos H. BarriosLeisha A. EmensSherene LoiSylvia AdamsVéronique DièrasPeter Schmid
- Topics
- Cancer Immunotherapy and Biomarkers (29 papers)Breast Cancer Treatment Studies (22 papers)Advanced Breast Cancer Therapies (21 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Jane Yuet Ching Hui
91 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Oncology 4.9k
- Pulmonary and Respiratory Medicine 1.8k
- Cancer Research 1.7k
- Immunology 1.7k
- Molecular Biology 975
Countries citing papers authored by Jane Yuet Ching Hui
This map shows the geographic impact of Jane Yuet Ching Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Yuet Ching Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Yuet Ching Hui more than expected).
Fields of papers citing papers by Jane Yuet Ching Hui
This network shows the impact of papers produced by Jane Yuet Ching Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Yuet Ching Hui. The network helps show where Jane Yuet Ching Hui may publish in the future.
Co-authorship network of co-authors of Jane Yuet Ching Hui
This figure shows the co-authorship network connecting the top 25 collaborators of Jane Yuet Ching Hui. A scholar is included among the top collaborators of Jane Yuet Ching Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Yuet Ching Hui. Jane Yuet Ching Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 12 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 6 | |
| 7 | 0 | |
| 8 | 2 | |
| 9 | 8 | |
| 10 | 0 | |
| 11 | 3 | |
| 12 | 8 | |
| 13 | 7 | |
| 14 | 2 | |
| 15 | 44 | |
| 16 | Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trialbreakdown → | 846 |
| 17 | 20 | |
| 18 | 1 | |
| 19 | 49 | |
| 20 | 97 |
About Jane Yuet Ching Hui
Jane Yuet Ching Hui is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 101 papers that have together received 6.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (29 papers), Breast Cancer Treatment Studies (22 papers) and Advanced Breast Cancer Therapies (21 papers). The work is most often cited by research in Oncology (4.9k citations), Cancer Research (1.7k citations) and Immunology (1.7k citations). Jane Yuet Ching Hui has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Hiroji Iwata, Luciana Molinero, Carlos H. Barrios, Leisha A. Emens, Sherene Loi, Sylvia Adams, Véronique Dièras, Peter Schmid, Hope S. Rugo and Eric P. Winer. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.